Tamar Securities, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tamar Securities, LLC

  • $710 Million
  • Q3 2024

A detailed history of Tamar Securities, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tamar Securities, LLC holds 15,492 shares of REGN stock, worth $11.5 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares
15,492
Previous 13,281 16.65%
Holding current value
$11.5 Million
Previous $14 Million 16.67%
% of portfolio
2.3%
Previous 2.27%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$1024.09 - $1201.76 $2.26 Million - $2.66 Million
2,211 Added 16.65%
15,492 $16.3 Million
Q2 2024

Oct 10, 2024
BUY
$883.2 - $1071.19 $212,851 - $258,156
241 Added 1.85%
13,281 $14 Million
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $194,981 - $214,563
-216 Reduced 1.52%
14,012 $13.5 Million
Q4 2023

Jan 24, 2024
BUY
$775.18 - $881.7 $1.05 Million - $1.19 Million
1,354 Added 10.52%
14,228 $12.5 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $155,108 - $189,138
224 Added 1.77%
12,874 $10.6 Million
Q2 2023

Oct 10, 2024
BUY
$700.03 - $830.35 $1.1 Million - $1.3 Million
1,570 Added 13.69%
13,040 $9.37 Million
Q1 2023

Oct 10, 2024
SELL
$680.49 - $826.97 $1.73 Million - $2.1 Million
-2,542 Reduced 18.14%
11,470 $9.42 Million
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $81,883 - $88,901
-116 Reduced 0.91%
12,650 $9.13 Million
Q3 2022

Nov 04, 2022
BUY
$573.97 - $724.32 $278,949 - $352,019
486 Added 3.96%
12,766 $8.79 Million
Q2 2022

Aug 05, 2022
BUY
$548.35 - $738.84 $174,923 - $235,689
319 Added 2.67%
12,280 $7.26 Million
Q1 2022

Apr 27, 2022
BUY
$595.12 - $698.43 $808,172 - $948,467
1,358 Added 12.81%
11,961 $8.35 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $82,608 - $101,987
-152 Reduced 1.41%
10,603 $6.7 Million
Q3 2021

Oct 19, 2021
SELL
$574.03 - $680.96 $43,626 - $51,752
-76 Reduced 0.7%
10,755 $6.51 Million
Q2 2021

Aug 06, 2021
BUY
$472.8 - $558.54 $325,759 - $384,834
689 Added 6.79%
10,831 $6.05 Million
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $850,573 - $1.04 Million
1,904 Added 23.11%
10,142 $4.8 Million
Q4 2020

Jan 27, 2021
BUY
$478.3 - $607.98 $319,026 - $405,522
667 Added 8.81%
8,238 $3.98 Million
Q3 2020

Nov 05, 2020
BUY
$544.75 - $658.21 $257,122 - $310,675
472 Added 6.65%
7,571 $4.24 Million
Q2 2020

Sep 10, 2020
BUY
$493.32 - $643.92 $3.5 Million - $4.57 Million
7,099 New
7,099 $4.43 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Tamar Securities, LLC Portfolio

Follow Tamar Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamar Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tamar Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email